Prior to joining UGA, Dr. Hallow worked for five years in pharmacometric modeling and simulation at Novartis Pharmaceuticals. She received her B.S. in 2002 and Ph.D. in 2007, both in Mechanical Engineering, from the Georgia Tech. Dr. Hallow's research involves using mathematical models of cardiovascular and metabolic physiology to better understand disease mechanisms and physiological determinants of variable response to therapies, and as a basis for model-based, personalized mobile health tools aimed at improving treatment adherence.